| Product Code: ETC13155510 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Preimplantation Genetic Diagnosis Market was valued at USD 1 Billion in 2024 and is expected to reach USD 1.5 Billion by 2031, growing at a compound annual growth rate of 7.10% during the forecast period (2025-2031).
The Global Preimplantation Genetic Diagnosis (PGD) Market is experiencing steady growth due to increasing awareness about genetic disorders, advancements in genetic testing technologies, and rising demand for effective infertility treatments. PGD is a technique used during in vitro fertilization to screen embryos for genetic abnormalities before implantation, reducing the risk of passing on inherited diseases to offspring. Key factors driving market growth include the growing prevalence of genetic disorders, rising infertility rates, and expanding applications of PGD beyond traditional indications. The market is characterized by key players offering a range of PGD services and products, with North America and Europe leading in market share due to well-established healthcare infrastructure and high adoption rates of advanced medical technologies. The Asia-Pacific region is also emerging as a lucrative market with increasing investments in healthcare infrastructure and rising awareness about genetic testing.
The Global Preimplantation Genetic Diagnosis (PGD) Market is experiencing significant growth driven by increasing awareness about genetic disorders, rising infertility rates, and advancements in genetic testing technologies. Key trends include a growing demand for personalized medicine, adoption of non-invasive PGD techniques, and expanding applications beyond traditional genetic testing. Opportunities in the market lie in the development of more accurate and cost-effective PGD technologies, expanding market penetration in emerging economies, and integration of artificial intelligence and big data analytics for enhanced genetic testing capabilities. Additionally, collaborations between healthcare providers and genetic testing companies, along with favorable government initiatives supporting genetic testing services, are expected to further fuel market growth in the coming years.
The Global Preimplantation Genetic Diagnosis (PGD) Market faces several challenges, including ethical concerns surrounding the selection of embryos based on genetic traits, limited access to PGD due to high costs, and varying regulations across different countries. Additionally, there are technical challenges related to the accuracy and reliability of genetic testing methods used in PGD, as well as the risk of misdiagnosis or genetic mosaicism. Furthermore, the lack of awareness and understanding among patients and healthcare providers about the benefits and limitations of PGD can also hinder market growth. Overcoming these challenges will require advancements in technology, increased affordability and accessibility of PGD services, as well as ongoing education and advocacy efforts to promote ethical and responsible use of genetic testing in assisted reproduction.
The Global Preimplantation Genetic Diagnosis (PGD) Market is primarily driven by the increasing prevalence of genetic disorders and chromosomal abnormalities, which has boosted the demand for advanced genetic testing technologies. The rising awareness among individuals about the benefits of PGD in preventing the transmission of genetic diseases to offspring is also a key driver. Additionally, the growing trend of delaying parenthood, coupled with the rising infertility rates globally, has led to an increase in the number of couples opting for assisted reproductive technologies like in vitro fertilization (IVF) with PGD. Technological advancements in genetic screening techniques, favorable reimbursement policies, and the expanding applications of PGD in detecting mutations associated with inherited diseases further contribute to the market growth.
Government policies related to the Global Preimplantation Genetic Diagnosis (PGD) Market vary by country but generally involve regulations on the use of PGD for assisted reproductive purposes. In the United States, the FDA regulates the use of PGD as a medical procedure, ensuring safety and efficacy. In the European Union, there are guidelines set by the European Society of Human Reproduction and Embryology (ESHRE) that govern the use of PGD. These guidelines include restrictions on the types of genetic conditions that can be screened for and the ethical considerations surrounding PGD. Overall, government policies aim to balance the advancement of genetic technologies with ethical considerations and patient safety in the rapidly evolving field of PGD.
The Global Preimplantation Genetic Diagnosis (PGD) Market is expected to witness significant growth in the coming years due to increasing awareness about genetic disorders, advancements in genetic testing technologies, and rising demand for assisted reproductive techniques. The market is likely to be driven by factors such as the growing prevalence of genetic diseases, rising infertility rates, and expanding applications of PGD beyond traditional genetic screening. Additionally, favorable government initiatives and investments in research and development activities are anticipated to propel market growth. However, challenges related to ethical concerns, high costs associated with PGD procedures, and regulatory complexities may hinder the market expansion to some extent. Overall, the Global PGD Market is poised for steady growth as technological innovations and strategic collaborations continue to drive advancements in the field of genetic testing and assisted reproduction.
The global preimplantation genetic diagnosis market showcases varying trends across regions. In Asia, the market is witnessing rapid growth due to increasing awareness about genetic testing and rising disposable incomes. North America leads the market, driven by advanced healthcare infrastructure and high adoption rates of genetic screening technologies. Europe follows closely, with a well-established regulatory framework supporting the widespread use of preimplantation genetic diagnosis. The Middle East and Africa region is experiencing moderate growth, with improving healthcare facilities and rising focus on reducing genetic disorders. Latin America is also emerging as a promising market, supported by growing investments in healthcare and rising demand for advanced genetic testing services. Overall, regional dynamics in the global preimplantation genetic diagnosis market reflect a mix of opportunities and challenges driven by factors such as regulatory environment, healthcare infrastructure, and awareness levels.
Global Preimplantation Genetic Diagnosis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Preimplantation Genetic Diagnosis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Preimplantation Genetic Diagnosis Market - Industry Life Cycle |
3.4 Global Preimplantation Genetic Diagnosis Market - Porter's Five Forces |
3.5 Global Preimplantation Genetic Diagnosis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Preimplantation Genetic Diagnosis Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
4 Global Preimplantation Genetic Diagnosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Preimplantation Genetic Diagnosis Market Trends |
6 Global Preimplantation Genetic Diagnosis Market, 2021 - 2031 |
6.1 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Chromosomal Abnormalities, 2021 - 2031 |
6.1.3 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Aneuploidy, 2021 - 2031 |
6.1.4 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By X-linked diseases, 2021 - 2031 |
6.1.5 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Single Gene Disorders, 2021 - 2031 |
6.1.6 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By HLA Typing, 2021 - 2031 |
6.1.7 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Gender selection, 2021 - 2031 |
6.1.8 Global Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.3.1 Overview & Analysis |
7 North America Preimplantation Genetic Diagnosis Market, Overview & Analysis |
7.1 North America Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
8 Latin America (LATAM) Preimplantation Genetic Diagnosis Market, Overview & Analysis |
8.1 Latin America (LATAM) Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
9 Asia Preimplantation Genetic Diagnosis Market, Overview & Analysis |
9.1 Asia Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
10 Africa Preimplantation Genetic Diagnosis Market, Overview & Analysis |
10.1 Africa Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
11 Europe Preimplantation Genetic Diagnosis Market, Overview & Analysis |
11.1 Europe Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
12 Middle East Preimplantation Genetic Diagnosis Market, Overview & Analysis |
12.1 Middle East Preimplantation Genetic Diagnosis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Preimplantation Genetic Diagnosis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Preimplantation Genetic Diagnosis Market, Revenues & Volume, By Test Type, 2021 - 2031 |
13 Global Preimplantation Genetic Diagnosis Market Key Performance Indicators |
14 Global Preimplantation Genetic Diagnosis Market - Export/Import By Countries Assessment |
15 Global Preimplantation Genetic Diagnosis Market - Opportunity Assessment |
15.1 Global Preimplantation Genetic Diagnosis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Preimplantation Genetic Diagnosis Market Opportunity Assessment, By Test Type, 2021 & 2031F |
16 Global Preimplantation Genetic Diagnosis Market - Competitive Landscape |
16.1 Global Preimplantation Genetic Diagnosis Market Revenue Share, By Companies, 2024 |
16.2 Global Preimplantation Genetic Diagnosis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here